Ryan Daniels
Analyst at William Blair
Replay available
Evolent Health, Inc. (NYSE: EVH) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Analyst at William Blair
Facilitator
Analyst at Citizen
Analyst at BTIG
Analyst at TD Callen
Chief Executive Officer
Analyst at Needham
Analyst at KeyBank
Chief Financial Officer
Analyst at JP Morgan (asking on behalf of Anne Samuel)
Analyst at Citi
Analyst at Piper Sandler
Welcome to the Evelyn Earnings Conference Call for the first quarter ended March 31st, 2025. As a reminder, this conference call is being recorded. Your hosts for the call today from Evelyn are Seth Blackley, Chief Executive Officer, and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Relations. This conference call will contain four looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our first quarter press release issued earlier today. Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the investor relations section of the website. or in the company's press release issued today and posted on the investor relations website, ir.evalence.com, and the form 8K filed by the company with the SEC earlier today. In addition to these reconciliations, we provide details on the numbers and operating metrics for the quarter in both our press release and supplemental investor presentation. And now I will turn the call over to Evelyn's CEO, Seth Blackley. Good evening, everybody, and thanks for joining the call. I'm happy to be here tonight to...